Publication: Putamen–midbrain functional connectivity is related to striatal dopamine transporter availability in patients with Lewy body diseases
Open/View Files
Date
2015
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Rieckmann, A., S.N. Gomperts, K.A. Johnson, J.H. Growdon, and K.R.A. Van Dijk. 2015. “Putamen–midbrain functional connectivity is related to striatal dopamine transporter availability in patients with Lewy body diseases.” NeuroImage : Clinical 8 (1): 554-559. doi:10.1016/j.nicl.2015.06.001. http://dx.doi.org/10.1016/j.nicl.2015.06.001.
Research Data
Abstract
Prior work has shown that functional connectivity between the midbrain and putamen is altered in patients with impairments in the dopamine system. This study examines whether individual differences in midbrain–striatal connectivity are proportional to the integrity of the dopamine system in patients with nigrostriatal dopamine loss (Parkinson's disease and dementia with Lewy bodies). We assessed functional connectivity of the putamen during resting state fMRI and dopamine transporter (DAT) availability in the striatum using 11C-Altropane PET in twenty patients. In line with the hypothesis that functional connectivity between the midbrain and the putamen reflects the integrity of the dopaminergic neurotransmitter system, putamen–midbrain functional connectivity was significantly correlated with striatal DAT availability even after stringent control for effects of head motion. DAT availability did not relate to functional connectivity between the caudate and thalamus/prefrontal areas. As such, resting state functional connectivity in the midbrain–striatal pathway may provide a useful indicator of underlying pathology in patients with nigrostriatal dopamine loss.
Description
Other Available Sources
Keywords
Functional connectivity, fMRI, PET, Dopamine transporter, Lewy body diseases, LBD, Lewy body diseases, DAT, dopamine transporter, UPDRS, Unified Parkinson's Disease Rating Scale, ROI, region of interest, DVR, distribution volume ratio
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service